CD274 and head and neck squamous cell carcinoma: It must be noted that in the neoadjuvant setting, treating locally-advanced HNSCC prior to surgery, higher overall response rates to anti-PD-(L)1 ICI have been reported compared with the recurrent/metastatic HNSCC setting.53